TY  - GEN
AU  - Tcheng,J E
TI  - Enhancing safety and outcomes with the newer antithrombotic and antiplatelet agents
SN  - 0002-8703
PY  - 1995///1006
KW  - Abciximab
KW  - Antibodies, Monoclonal
KW  - adverse effects
KW  - Clinical Trials as Topic
KW  - Eptifibatide
KW  - Fibrinolytic Agents
KW  - Humans
KW  - Immunoglobulin Fab Fragments
KW  - Peptides
KW  - Platelet Aggregation Inhibitors
KW  - Safety
N1  - Publication Type: Journal Article; Review
UR  - https://doi.org/10.1016/0002-8703(95)90305-4
ER  -